| Trial ID: | L0077 |
| Source ID: | NCT03636932
|
| Associated Drug: |
N-Acetylcysteine (Nac)
|
| Title: |
RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteine
|
| Acronym: |
RENACTIF
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Diseases
|
| Interventions: |
DRUG: N-acetylcysteine (NAC)|DRUG: Placebo|BIOLOGICAL: Blood sample|BIOLOGICAL: Blood sample
|
| Outcome Measures: |
Primary: compare the effect of N-acetylcysteine (NAC) intravenously administered, show a 33% decrease in circulating tissue factor levels in the N-acetylcysteine (NAC) group, 12 months |
|
| Sponsor/Collaborators: |
Sponsor: Assistance Publique Hopitaux De Marseille
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2019-04-30
|
| Completion Date: |
2023-05-23
|
| Results First Posted: |
|
| Last Update Posted: |
2023-05-24
|
| Locations: |
Assistance Publique Hôpitaux de Marseille, Marseille, 13354, France
|
| URL: |
https://clinicaltrials.gov/show/NCT03636932
|
